Automated And Closed Cell Therapy Processing Systems Market to Reach $2.86 Billion by 2029, Growing at a CAGR of 16.9%
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Global Market Value Of The Automated And Closed Cell Therapy Processing Systems Industry In 2025?
The market size for automated and closed cell therapy processing systems has seen substantial growth over recent years. Forecasts suggest a rise from $1.31 billion in 2024 to $1.53 billion in 2025, achieving a compound annual growth rate (CAGR) of 17.2%. Historically, this expansion was driven by a heightened demand for personalized medicine, an expanding cell and gene therapy pipeline, an increase in clinical trials for cell-based therapies, the scaling up of biopharmaceutical manufacturing capabilities, and enhanced investment in regenerative medicine.
The automated and closed cell therapy processing systems market is poised for significant expansion over the next few years. This market is expected to reach $2.86 billion by 2029, growing at a compound annual growth rate (CAGR) of 16.9%. This anticipated growth is driven by the increasing adoption of automation in cell therapy manufacturing, greater regulatory support for advanced therapy medicinal products, a growing need for scalable and reproducible processes, the expansion of cell therapy applications beyond oncology, and the rising demand for cost-effective manufacturing solutions. Key trends influencing the market during the forecast period include technological advancements in automated cell processing platforms, innovations in closed-system bioreactors, developments in artificial intelligence integration, ongoing research and development in modular manufacturing systems, and an increasing focus on end-to-end process automation.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27214&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Automated And Closed Cell Therapy Processing Systems Industry?
The expanding need for personalized medicine is projected to boost the automated and closed cell therapy processing systems market in the future. This medical approach involves customizing treatments and healthcare choices based on an individual’s distinct genetic, molecular, and clinical characteristics. Patients are increasingly requesting personalized medicine as it offers customized treatments that enhance efficacy, minimize adverse reactions, and suit their specific biological composition. Automated and closed-cell therapy processing systems facilitate personalized medicine by allowing for the precise, sterile, and uniform production of patient-specific therapies, reducing contamination and the need for manual handling. As an illustration, in February 2024, data from the Personalized Medicine Coalition, a US-based hospital and healthcare organization, indicated that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, sanctioned 16 novel personalized therapies for patients with rare diseases, an increase from six approvals in 2022. Consequently, the rising demand for personalized medicine is a key factor propelling the expansion of the automated and closed-cell therapy processing systems market.
How Is The Automated And Closed Cell Therapy Processing Systems Market Classified Into Different Segments?
The automated and closed cell therapy processing systems market covered in this report is segmented
1) By Component: Software, Hardware, Consumables
2) By Technology: Microfluidics, Robotics, Bioreactors, Single-Use Technology, Three-Dimensional (3D) Cell Culture
3) By Workflow: Cryopreservation, Separation, Fill-Finish, Expansion, Apheresis, Other Workflows
4) By Application: Oncology, Regenerative Medicine, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Contract Manufacturing Organizations, Hospitals
Subsegment:
1) By Software: Process Control Software, Data Management Software, Quality Monitoring Software, Workflow Automation Software, Integration Software
2) By Hardware: Cell Separation Devices, Bioreactors, Fluid Handling Systems, Centrifuges, Tubing And Connectors
3) By Consumables: Sterile Bags, Culture Media, Reagents And Buffers, Filters And Cartridges, Single-Use Tubing Sets
What Are The Latest Industry Trends Transforming The Automated And Closed Cell Therapy Processing Systems Market?
Leading companies in the automated and closed cell therapy processing systems market are concentrating on developing advanced solutions, such as cell preparation platforms, to minimize manual labor and the risk of contamination during cell processing. These cell preparation platforms are automated systems utilized for the efficient isolation, processing, and preparation of cells for subsequent analysis or clinical application. For example, in October 2024, Sino-Biocan Biotechnology Ltd., a China-based biotech company, introduced the WUKONG Automated, Closed, Integrated Cell Processing System. This launch represents a significant advancement in cell therapy manufacturing, as it provides a fully automated, closed platform that streamlines operations from blood collection to cell culture and final filling. The system is engineered to cater to hospitals, pharmaceutical research and development teams, and contract development and manufacturing organizations by boosting efficiency, lowering contamination risks, and ensuring good manufacturing practice-grade consistency through intelligent controls and real-time monitoring.
Who Are The Prominent Global Companies Shaping The Automated And Closed Cell Therapy Processing Systems Market?
Major companies operating in the automated and closed cell therapy processing systems market are Thermo Fisher Scientific Inc., Fresenius SE & Co. KGaA, Danaher Corporation, Merck KGaA, Parker Hannifin Corp., Corning Incorporated, Kawasaki Heavy Industries Ltd., Dover Corporation, Lonza Group AG, Terumo Corporation, Sartorius AG, Charles River Laboratories International Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Repligen Corporation, Cellares Inc., Ori Biotech Ltd., and Autolus Therapeutics Plc.
Download The Full Report For Exclusive Market Findings:
How Do Regional Market Performances Compare Within The Automated And Closed Cell Therapy Processing Systems Industry?
North America was the largest region in the automated and closed cell therapy processing systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated and closed cell therapy processing systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Automated And Closed Cell Therapy Processing Systems Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27214&type=smp
Browse Through More Reports Similar to the Global Automated And Closed Cell Therapy Processing Systems Market 2025, By The Business Research Company
Precision Engineering Machines Global Market Report 2025
People Counting System Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/people-counting-system-global-market-report
Sorting Machines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/sorting-machines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model